Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.2.7 ↗At a glance
Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Ruiyi Ren and 3 co-authors. Institution: Boston University School of Medicine, Department of Ophthalmology, Boston, Massachusetts, United States. Major MEDLINE topics: Glaucoma, Ocular Hypertension. Cited 20 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Boston University School of Medicine, Department of Ophthalmology, Boston, Massachusetts, United States.
- Aerie Pharmaceuticals, Inc., Durham, North Carolina, United States.
Funding
- NEI NIH HHS
Cite
APA
Ren, R., Humphrey, A. A., Kopczynski, C., & Gong, H. (2023). Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.2.7
Vancouver
Ren R, Humphrey AA, Kopczynski C, Gong H. Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.2.7
BibTeX
@article{Ren2023,
author = {Ren, Ruiyi and Humphrey, Anne A and Kopczynski, Casey and Gong, Haiyan},
title = {Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.2.7}
}
EUVIMED